Cargando…

Intralesional Injection of Hyaluronic Acid in Patients Affected With Peyronie's Disease: Preliminary Results From a Prospective, Multicenter, Pilot Study

INTRODUCTION: Hyaluronic acid has been shown to be efficacious in decreasing scar formation, inflammation, and oxidative stress. AIM: To assess the efficacy of intralesional injection of hyaluronic acid in patients affected by Peyronie's disease. METHODS: In this prospective, single-arm, self-c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zucchi, Alessandro, Costantini, Elisabetta, Cai, Tommaso, Cavallini, Giorgio, Liguori, Giovanni, Favilla, Vincenzo, De Grande, Gaetano, D'Achille, Giuseppe, Silvani, Mauro, Franco, Giorgio, Palmieri, Alessandro, Verze, Paolo, Mirone, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005307/ https://www.ncbi.nlm.nih.gov/pubmed/26984291 http://dx.doi.org/10.1016/j.esxm.2016.01.002

Ejemplares similares

Oral Administration and Intralesional Injection of Hyaluronic Acid Versus Intralesional Injection Alone in Peyronie's Disease: Results from a Phase III Study
por: Cai, Tommaso, et al.
Publicado: (2021)

Expanded Utilization of Intralesional Therapies for Treatment of Peyronie’s Disease
por: Khooblall, Prajit, et al.
Publicado: (2023)

Comparison of Intralesional Hyaluronic Acid vs. Verapamil for the Treatment of Acute Phase Peyronie's Disease: A Prospective, Open-Label Non-Randomized Clinical Study
por: Cocci, Andrea, et al.
Publicado: (2021)

The Use of Vacuum Devices as Adjuvant Therapy before and after Penile Curvature Surgery in Patients Affected by La Peyronie’s Disease: Results from a Comparative Study
por: Cai, Tommaso, et al.
Publicado: (2023)

Xyloglucan, Hibiscus and Propolis in the Management of Uncomplicated Lower Urinary Tract Infections: A Systematic Review and Meta-Analysis
por: Cai, Tommaso, et al.
Publicado: (2021)

The Clinical Efficacy of Pollen Extract and Vitamins on Chronic Prostatitis/Chronic Pelvic Pain Syndrome Is Linked to a Decrease in the Pro-Inflammatory Cytokine Interleukin-8
por: Cai, Tommaso, et al.
Publicado: (2017)

Premature Ejaculation Among Italian Men: Prevalence and Clinical Correlates From an Observational, Non-Interventional, Cross-Sectional, Epidemiological Study (IPER)
por: Verze, Paolo, et al.
Publicado: (2018)

Racial variations in response to intralesional collagenase clostridium histolyticum in men with Peyronie’s disease
por: Nguyen, Hoang Minh Tue, et al.
Publicado: (2017)

Intralesional collagenase may improve pain and curvature in acute phase Peyronie’s patients
por: Fisher, John Samuel, et al.
Publicado: (2022)

Collagenase clostridium histolyticum intralesional injections for the treatment of Peyronie’s disease: a safety profile
por: Yan, Sylvia, et al.
Publicado: (2017)

Complications and other concerns with intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Levine, Laurence A.
Publicado: (2017)

Clinical and epidemiological characteristics of young patients with Peyronie’s disease: a retrospective study
por: Paulis, Gianni, et al.
Publicado: (2015)

How the andrological sector suffered from the dramatic Covid 19 outbreak in Italy: supportive initiatives of the Italian Association of Andrology (SIA)
por: Rizzo, Michele, et al.
Publicado: (2020)

Role of PA2G4P4 pseudogene in bladder cancer tumorigenesis
por: Pisapia, Laura, et al.
Publicado: (2020)

Tadalafil once daily and intralesional verapamil injection: A new therapeutic direction in Peyronie's disease
por: Dell’Atti, Lucio
Publicado: (2015)

Prospective study to evaluate the clinical outcome of intralesional interferon-α2b in the management of Peyronie's disease
por: Sokhal, Ashok Kumar, et al.
Publicado: (2018)

Prostate calcifications: A case series supporting the microbial biofilm theory
por: Cai, Tommaso, et al.
Publicado: (2018)

Clinical use of hyaluronic acid in andrology: A review
por: Zucchi, Alessandro, et al.
Publicado: (2021)

Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Kadioglu, Ates, et al.
Publicado: (2017)

Intralesional collagenase Clostridium histolyticum for acute phase Peyronie’s disease: a single-center, retrospective cohort study
por: Hu, Ming-Yeah Y., et al.
Publicado: (2022)

The role of flower pollen extract in managing patients affected by chronic prostatitis/chronic pelvic pain syndrome: a comprehensive analysis of all published clinical trials
por: Cai, Tommaso, et al.
Publicado: (2017)

Re: Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Kahn, Barbara, et al.
Publicado: (2017)

The efficacy and safety of intralesional injection of collagenase Clostridium histolyticum for Peyronie’s disease: A meta-analysis of published prospective studies
por: Zhang, Fuxun, et al.
Publicado: (2022)

Use of penile shear wave elastosonography for the diagnosis of Peyronie’s Disease: a prospective case–control study
por: Trama, Francesco, et al.
Publicado: (2022)

Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie’s disease: a case-control study
por: Paulis, Gianni, et al.
Publicado: (2015)

Rhodiola rosea, folic acid, zinc and biotin (EndEP(®)) is able to improve ejaculatory control in patients affected by lifelong premature ejaculation: Results from a phase I-II study
por: Cai, Tommaso, et al.
Publicado: (2016)

Treatment of Peyronie’s disease via preoperative intralesional collagenase clostridium histolyticum followed by placement of an inflatable penile prosthesis: the new standard of care?
por: Akerman, Jason, et al.
Publicado: (2017)

Cost of Intralesional Collagenase Clostridium Histiolyticum Therapy Versus Surgery for the Management of Peyronie's Disease: A Claims-Based Analysis (2009–2019)
por: Walton, Eric L., et al.
Publicado: (2022)

Chlamydia trachomatis versus common uropathogens as a cause of chronic bacterial prostatitis: Is there any difference? Results of a prospective parallel-cohort study
por: Cai, Tommaso, et al.
Publicado: (2017)

Pollen extract in association with vitamins provides early pain relief in patients affected by chronic prostatitis/chronic pelvic pain syndrome
por: CAI, TOMMASO, et al.
Publicado: (2014)

In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid
por: Cermelli, Claudio, et al.
Publicado: (2011)

Role of Oxidative Stress in Peyronie’s Disease: Biochemical Evidence and Experiences of Treatment with Antioxidants
por: Paulis, Gianni, et al.
Publicado: (2022)

Disappearance of Plaque Following Treatment with Antioxidants in Peyronie’s Disease Patients—A Report of 3 Cases
por: Paulis, Gianni, et al.
Publicado: (2022)

The pathophysiology of Peyronie’s disease
por: El-Sakka, Ahmed I., et al.
Publicado: (2013)

Peyronie’s penile plication
por: Cordon, Billy H., et al.
Publicado: (2017)

Peyronie’s disease: is it genetic or not?
por: Gabrielsen, J. Scott
Publicado: (2020)

Portrait of La Peyronie
Publicado: (1939)

Association Between the Neurogenic Bladder Symptom Score and Urodynamic Examination in Multiple Sclerosis Patients With Lower Urinary Tract Dysfunction
por: Fragalà, Eugenia, et al.
Publicado: (2015)

Polyphenols: Key Issues Involved in Chemoprevention of Prostate Cancer
por: Cimino, Sebastiano, et al.
Publicado: (2012)

When technological innovations do not reach consensus: the case of tele-consultation of andrological patients
por: Verze, Paolo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iqi27cotfhs05j3ghdsh3os4ga